387086006: lévodopa (substance)

SNOMED CT Concept\substance\...

\Substance categorized by disposition\Receptor agonist\Dopamine receptor agonist\Dihydroxyphenylalanine\Levodopa (substance)

\Drug or medicament (substance)\Central nervous system agent (substance)\Antiparkinsonian agent (substance)\Dihydroxyphenylalanine\Levodopa (substance)

\substance catégorisée selon sa structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Catecholamine and/or catecholamine derivative\Catecholamine\Dihydroxyphenylalanine\Levodopa (substance)

\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Catecholamine and/or catecholamine derivative\Catecholamine\Dihydroxyphenylalanine\Levodopa (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Levodopa (substance)	est un(e) (attribut)	Dopamine agent (substance)	false	Inferred relationship	Some
Levodopa (substance)	est un(e) (attribut)	Dihydroxyphenylalanine	true	Inferred relationship	Some
Levodopa (substance)	Has disposition (attribute)	Dopamine receptor agonist (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Co-beneldopa 12.5mg/50mg dispersible tablet (product)	a pour principe actif (attribut)	False	Levodopa (substance)	Inferred relationship	Some
Co-beneldopa 25mg/100mg m/r capsule (product)	a pour principe actif (attribut)	False	Levodopa (substance)	Inferred relationship	Some
Co-beneldopa 25mg/100mg dispersible tablet (product)	a pour principe actif (attribut)	False	Levodopa (substance)	Inferred relationship	Some
Product containing benserazide and levodopa (medicinal product)	a pour principe actif (attribut)	True	Levodopa (substance)	Inferred relationship	Some	1
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug)	a pour principe actif (attribut)	False	Levodopa (substance)	Inferred relationship	Some
Carbidopa 18.75mg + levodopa 75mg + entacapone 200mg tablet	a pour principe actif (attribut)	False	Levodopa (substance)	Inferred relationship	Some
Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet	a pour principe actif (attribut)	False	Levodopa (substance)	Inferred relationship	Some
Allergy to levodopa	Causative agent	True	Levodopa (substance)	Inferred relationship	Some	1
Product containing carbidopa and levodopa in oral dose form (medicinal product form)	a pour principe actif (attribut)	True	Levodopa (substance)	Inferred relationship	Some	1
Carbidopa 12.5 mg and levodopa 50 mg oral tablet	a pour principe actif (attribut)	False	Levodopa (substance)	Inferred relationship	Some	1
Carbidopa 12.5 mg and levodopa 50 mg oral tablet	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Some	1
Carbidopa 10 mg and levodopa 100 mg oral tablet	a pour principe actif (attribut)	False	Levodopa (substance)	Inferred relationship	Some	2
Carbidopa 10 mg and levodopa 100 mg oral tablet	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Some	2
Carbidopa 25 mg and levodopa 100 mg oral tablet	a pour principe actif (attribut)	False	Levodopa (substance)	Inferred relationship	Some	1
Carbidopa 25 mg and levodopa 100 mg oral tablet	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Some	1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet	Has basis of strength substance (attribute)	True	Levodopa (substance)	Inferred relationship	Some	2
Levodopa 500 mg oral tablet	a pour principe actif (attribut)	False	Levodopa (substance)	Inferred relationship	Some	1
Levodopa 500 mg oral tablet	Has basis of strength substance (attribute)	True	Levodopa (substance)	Inferred relationship	Some	1
Carbidopa 10 mg and levodopa 100 mg oral tablet	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Some	1
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	a pour principe actif (attribut)	False	Levodopa (substance)	Inferred relationship	Some	2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Levodopa (substance)	Inferred relationship	Some	2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug)	a pour principe actif (attribut)	False	Levodopa (substance)	Inferred relationship	Some	2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Levodopa (substance)	Inferred relationship	Some	2
Carbidopa 25 mg and levodopa 100 mg oral tablet	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Some	2
Carbidopa 25 mg and levodopa 250 mg oral tablet	a pour principe actif (attribut)	False	Levodopa (substance)	Inferred relationship	Some	2
Carbidopa 25 mg and levodopa 250 mg oral tablet	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Some	2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Some	1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet	a pour principe actif (attribut)	False	Levodopa (substance)	Inferred relationship	Some	1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Some	1
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug)	a pour principe actif (attribut)	False	Levodopa (substance)	Inferred relationship	Some	1
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Some	1
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Some	3
Carbidopa 12.5 mg and levodopa 50 mg oral tablet	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Some	2
Product containing carbidopa and levodopa in enteral dose form (medicinal product form)	a pour principe actif (attribut)	True	Levodopa (substance)	Inferred relationship	Some	1
Co-beneldopa 25mg/100mg prolonged-release oral capsule (product)	a pour principe actif (attribut)	False	Levodopa (substance)	Inferred relationship	Some
Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Some	2
Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Has precise active ingredient	False	Levodopa (substance)	Inferred relationship	Some	2
Carbidopa (as carbidopa monohydrate) 25 mg and levodopa 100 mg prolonged-release oral tablet	Has precise active ingredient	False	Levodopa (substance)	Inferred relationship	Some	2
Carbidopa (as carbidopa monohydrate) 25 mg and levodopa 100 mg prolonged-release oral tablet	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Some	2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	False	Levodopa (substance)	Inferred relationship	Some	1
Carbidopa 25 mg and levodopa 100 mg oral tablet	Has precise active ingredient	False	Levodopa (substance)	Inferred relationship	Some	2
Carbidopa 25 mg and levodopa 250 mg oral tablet	Has precise active ingredient	False	Levodopa (substance)	Inferred relationship	Some	2
Levodopa 500 mg oral tablet	Has precise active ingredient	True	Levodopa (substance)	Inferred relationship	Some	1
Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)	a pour principe actif (attribut)	True	Levodopa (substance)	Inferred relationship	Some	2
Carbidopa 12.5 mg and levodopa 50 mg oral tablet	Has precise active ingredient	False	Levodopa (substance)	Inferred relationship	Some	2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	False	Levodopa (substance)	Inferred relationship	Some	3
Carbidopa 10 mg and levodopa 100 mg oral tablet	Has precise active ingredient	False	Levodopa (substance)	Inferred relationship	Some	1
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	False	Levodopa (substance)	Inferred relationship	Some	1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet	Has precise active ingredient	True	Levodopa (substance)	Inferred relationship	Some	2
Allergy to carbidopa and levodopa	Causative agent	False	Levodopa (substance)	Inferred relationship	Some	2
Allergy to benserazide and levodopa	Causative agent	False	Levodopa (substance)	Inferred relationship	Some	2

Start Page 2 of 2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461264012	Levodopa (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481200014	Levodopa	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1491864012	L-3-hydroxytyrosine	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
3766620018	L-dopa	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
620831000241118	lévodopa (substance)	fr	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
820521000172119	lévodopa	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)